The latest and 57th iteration of International Liver Congress™ (ILC 2022) returns as an in-person event in London this coming June (22–26). The event is being held at the ExCeL London exhibition centre, and online. The congress is convened annually by the European Association for the Study of the Liver (EASL) and is expected to attract some 8,000 researchers, […]
continue readingEASL Statement on cases of severe acute hepatitis in children of unknown causes
The European Association for the Study of the Liver (EASL) echoes the concerns of UK and WHO Europe officials on this unusual outbreak of severe acute hepatitis in children, originally in Europe, and more recently in Asia and North America. EASL concurs with experts that the common viruses that cause acute viral hepatitis have not […]
continue reading
A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope
More than ten million people worldwide suffer from decompensated cirrhosis, often as a result of severe alcoholic hepatitis (sAH) or other chronic liver diseases. In its final stages, decompensated cirrhosis leads to acute-on-chronic liver failure (ACLF), a syndrome characterised by multi-organ failure. Effective treatment of ACLF is an urgent and unmet need. The A-TANGO Consortium […]
continue reading